{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T00:21:53Z","timestamp":1720225313257},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,5]]},"DOI":"10.7759\/cureus.63894","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T11:33:26Z","timestamp":1720179206000},"source":"Crossref","is-referenced-by-count":0,"title":["Diagnostic Approach to IgG4-Related Retroperitoneal Fibrosis After Colorectal Cancer Surgery in a Patient With Normal IgG4 Levels: A Case Report"],"prefix":"10.7759","author":[{"given":"Eiichi","family":"Kakehi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kae","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruka","family":"Okutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiko","family":"Kotani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1104650","article-title":"IgG4-related disease","volume":"366","author":"Stone JH","year":"2012","unstructured":"Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012, 366:539-51. 10.1056\/NEJMra1104650","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa411","article-title":"Clinical features of IgG4-related retroperitoneal fibrosis among 407 patients with IgG4-related disease: a retrospective study","volume":"60","author":"Liu Y","year":"2021","unstructured":"Liu Y, Zhu L, Wang Z, et al.. Clinical features of IgG4-related retroperitoneal fibrosis among 407 patients with IgG4-related disease: a retrospective study. Rheumatology (Oxford). 2021, 60:767-72. 10.1093\/rheumatology\/keaa411","journal-title":"Rheumatology (Oxford)"},{"key":"ref3","article-title":"IgG4-related disease and isolated retroperitoneal fibrosis: a narrative review","volume":"2","author":"Razok A","year":"2023","unstructured":"Razok A, Romero Noboa ME, Sami F, Patolia KN, Tanveer S. IgG4-related disease and isolated retroperitoneal fibrosis: a narrative review. ARP Rheumatol. 2023, 2:155-7.","journal-title":"ARP Rheumatol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1002\/art.39773","article-title":"Association of IgG4-related disease with history of malignancy","volume":"68","author":"Wallace ZS","year":"2016","unstructured":"Wallace ZS, Wallace CJ, Lu N, Choi HK, Stone JH. Association of IgG4-related disease with history of malignancy. Arthritis Rheumatol. 2016, 68:2283-9. 10.1002\/art.39773","journal-title":"Arthritis Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/art.39686","article-title":"IgG4-related disease: retrospective analysis of one hundred sixty-six patients","volume":"68","author":"Sekiguchi H","year":"2016","unstructured":"Sekiguchi H, Horie R, Kanai M, Suzuki R, Yi ES, Ryu JH. IgG4-related disease: retrospective analysis of one hundred sixty-six patients. Arthritis Rheumatol. 2016, 68:2290-9. 10.1002\/art.39686","journal-title":"Arthritis Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15809","article-title":"Nationwide epidemiological survey of immunoglobulin G4-related disease with malignancy in Japan","volume":"37","author":"Sumimoto K","year":"2022","unstructured":"Sumimoto K, Uchida K, Ikeura T, et al.. Nationwide epidemiological survey of immunoglobulin G4-related disease with malignancy in Japan. J Gastroenterol Hepatol. 2022, 37:1022-33. 10.1111\/jgh.15809","journal-title":"J Gastroenterol Hepatol"},{"key":"ref7","article-title":"Clinical significance of soluble interleukin-2 receptor measurement in immune-mediated diseases","volume":"78","author":"Dik WA","year":"2020","unstructured":"Dik WA, Heron M. Clinical significance of soluble interleukin-2 receptor measurement in immune-mediated diseases. Neth J Med. 2020, 78:220-31.","journal-title":"Neth J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/6103064","article-title":"Soluble interleukin-2 receptor: a potential marker for monitoring disease activity in IgG4-related disease","volume":"2018","author":"Karim AF","year":"2018","unstructured":"Karim AF, Eurelings LE, Bansie RD, van Hagen PM, van Laar JA, Dik WA. Soluble interleukin-2 receptor: a potential marker for monitoring disease activity in IgG4-related disease. Mediators Inflamm. 2018, 2018:6103064. 10.1155\/2018\/6103064","journal-title":"Mediators Inflamm"},{"key":"ref9","article-title":"Utility of FDG-PET\/CT in the diagnosis of IgG4-related diseases","volume":"34","author":"Zhao Z","year":"2016","unstructured":"Zhao Z, Wang Y, Guan Z, Jin J, Huang F, Zhu J. Utility of FDG-PET\/CT in the diagnosis of IgG4-related diseases. Clin Exp Rheumatol. 2016, 34:119-25.","journal-title":"Clin Exp Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s13550-020-00743-w","article-title":"Disease activity and response to therapy monitored by [(18)F]FDG PET\/CT using volume-based indices in IgG4-related disease","volume":"10","author":"Mitamura K","year":"2020","unstructured":"Mitamura K, Arai-Okuda H, Yamamoto Y, et al.. Disease activity and response to therapy monitored by [(18)F]FDG PET\/CT using volume-based indices in IgG4-related disease. EJNMMI Res. 2020, 10:153. 10.1186\/s13550-020-00743-w","journal-title":"EJNMMI Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/art.41120","article-title":"The 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG4-related disease","volume":"72","author":"Wallace ZS","year":"2020","unstructured":"Wallace ZS, Naden RP, Chari S, et al.. The 2019 American College of Rheumatology\/European League Against Rheumatism classification criteria for IgG4-related disease. Arthritis Rheumatol. 2020, 72:7-19. 10.1002\/art.41120","journal-title":"Arthritis Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2020.1859710","article-title":"The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD","volume":"31","author":"Umehara H","year":"2021","unstructured":"Umehara H, Okazaki K, Kawa S, et al.. The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD. Mod Rheumatol. 2021, 31:529-33. 10.1080\/14397595.2020.1859710","journal-title":"Mod Rheumatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0800251","article-title":"Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1","volume":"358","author":"Hunder NN","year":"2008","unstructured":"Hunder NN, Wallen H, Cao J, et al.. Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1. N Engl J Med. 2008, 358:2698-703. 10.1056\/NEJMoa0800251","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.12.1330","article-title":"Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease","volume":"138","author":"Mattoo H","year":"2016","unstructured":"Mattoo H, Mahajan VS, Maehara T, et al.. Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease. J Allergy Clin Immunol. 2016, 138:825-38. 10.1016\/j.jaci.2015.12.1330","journal-title":"J Allergy Clin Immunol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3182431ef6","article-title":"Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients","volume":"91","author":"Khosroshahi A","year":"2012","unstructured":"Khosroshahi A, Carruthers MN, Deshpande V, Unizony S, Bloch DB, Stone JH. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine (Baltimore). 2012, 91:57-66. 10.1097\/MD.0b013e3182431ef6","journal-title":"Medicine (Baltimore)"},{"key":"ref16","article-title":"Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sj\u00f6gren's syndrome adults from a defined population","volume":"36 Suppl 112","author":"Akiyama M","year":"2018","unstructured":"Akiyama M, Sasaki T, Kaneko Y, Yasuoka H, Suzuki K, Yamaoka K, Takeuchi T. Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sj\u00f6gren's syndrome adults from a defined population. Clin Exp Rheumatol. 2018, 36 Suppl 112:157-64.","journal-title":"Clin Exp Rheumatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1080\/14397595.2017.1416739","article-title":"Serum soluble interleukin-2 receptor as a biomarker in immunoglobulin G4-related disease","volume":"28","author":"Handa T","year":"2018","unstructured":"Handa T, Matsui S, Yoshifuji H, et al.. Serum soluble interleukin-2 receptor as a biomarker in immunoglobulin G4-related disease. Mod Rheumatol. 2018, 28:838-44. 10.1080\/14397595.2017.1416739","journal-title":"Mod Rheumatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05484-8","article-title":"Prognostic factors in IgG4-related disease: a long-term monocentric Chinese cohort study","volume":"40","author":"Zongfei J","year":"2021","unstructured":"Zongfei J, Lingying M, Lijuan Z, et al.. Prognostic factors in IgG4-related disease: a long-term monocentric Chinese cohort study. Clin Rheumatol. 2021, 40:2293-300. 10.1007\/s10067-020-05484-8","journal-title":"Clin Rheumatol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1159\/000521423","article-title":"Retroperitoneal fibrosis is still an underdiagnosed entity with poor prognosis","volume":"47","author":"\u0141o\u0144 I","year":"2022","unstructured":"\u0141o\u0144 I, Wieliczko M, Lewandowski J, Ma\u0142yszko J. Retroperitoneal fibrosis is still an underdiagnosed entity with poor prognosis. Kidney Blood Press Res. 2022, 47:151-62. 10.1159\/000521423","journal-title":"Kidney Blood Press Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e31826b1c1d","article-title":"Malignant retroperitoneal fibrosis: MRI characteristics in 50 patients","volume":"91","author":"Mirault T","year":"2012","unstructured":"Mirault T, Lambert M, Puech P, et al.. Malignant retroperitoneal fibrosis: MRI characteristics in 50 patients. Medicine (Baltimore). 2012, 91:242-50. 10.1097\/MD.0b013e31826b1c1d","journal-title":"Medicine (Baltimore)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/270196-diagnostic-approach-to-igg4-related-retroperitoneal-fibrosis-after-colorectal-cancer-surgery-in-a-patient-with-normal-igg4-levels-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T11:33:30Z","timestamp":1720179210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/270196-diagnostic-approach-to-igg4-related-retroperitoneal-fibrosis-after-colorectal-cancer-surgery-in-a-patient-with-normal-igg4-levels-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,5]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.63894","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,5]]}}}